Megaloblastosis appeared in a patient receiving pyrimethamine. Pyrimethamine seemed to act as does the folate antagonist methotrexate in short-term in vitro culture of the patient's bone marrow. It produced defective deoxyuridine conversion to thymidylate, a defect that was corrected poorly by oxidized and well by reduced folate. Increased deoxyuridine did not correct the defect induced by pyrimethamine or methotrexate but did correct that produced by 5-fluorouracil. As has been suggested, pyrimethamine acts biochemically in man as an antifolate.
No takes yet. Share an insight, caveat, or question.
Waxman et al. (1969) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: